Gene · 3921
Papers1,692
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 1,692
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Drug Delivery via the Use of ECM-Mimetic Materials. | Front Bioeng Biotechnol | 2020 | 32133350 | PubTator, text mining | PubMed |
| Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex. | Mol Biol Cell | 2020 | 32129710 | PubTator, text mining | PubMed |
| Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer. | World J Gastroenterol | 2020 | 32103869 | PubTator, text mining | PubMed |
| Procyanidin C1 Inhibits Melanoma Cell Growth by Activating 67-kDa Laminin Receptor Signaling. | Mol Nutr Food Res | 2020 | 32103628 | PubTator, text mining | PubMed |
| Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix. | Cells | 2020 | 32079295 | PubTator, text mining | PubMed |
| Incomplete penetrance in primary immunodeficiency: a skeleton in the closet. | Hum Genet | 2020 | 32067110 | PubTator, text mining | PubMed |
| Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition. | Sci Rep | 2020 | 32047167 | PubTator, text mining | PubMed |
| AAV-Mediated Gene Delivery to 3D Retinal Organoids Derived from Human Induced Pluripotent Stem Cells. | Int J Mol Sci | 2020 | 32028585 | PubTator, text mining | PubMed |
| Structure guided prediction of Pyrazinamide resistance mutations in pncA. | Sci Rep | 2020 | 32024884 | PubTator, text mining | PubMed |
| AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System. | Mol Cell | 2020 | 31995728 | PubTator, text mining | PubMed |
| Selective inhibitors for JNK signalling: a potential targeted therapy in cancer. | J Enzyme Inhib Med Chem | 2020 | 31994958 | PubTator, text mining | PubMed |
| Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients. | J Cachexia Sarcopenia Muscle | 2020 | 31991054 | PubTator, text mining | PubMed |
| Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D. | Nat Commun | 2020 | 31980649 | PubTator, text mining | PubMed |
| Epigallocatechin Gallate Induces Upregulation of LDL Receptor via the 67 kDa Laminin Receptor-Independent Pathway in HepG2 Cells. | Mol Nutr Food Res | 2020 | 31978263 | PubTator, text mining | PubMed |
| Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. | J Clin Immunol | 2020 | 31953710 | PubTator, text mining | PubMed |
| Impact of juvenile hormone analogue insecticides on the water flea Moina macrocopa: Growth, reproduction and transgenerational effect. | Aquat Toxicol | 2020 | 31927065 | PubTator, text mining | PubMed |
| Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China. | BMC Infect Dis | 2020 | 31910878 | PubTator, text mining | PubMed |
| The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | J Biol Chem | 2020 | 31822558 | PubTator, text mining | PubMed |
| Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | Nat Chem Biol | 2020 | 31792442 | PubTator, text mining | PubMed |
| Foot-and-Mouth Disease Virus Capsid Protein VP1 Interacts with Host Ribosomal Protein SA To Maintain Activation of the MAPK Signal Pathway and Promote Virus Replication. | J Virol | 2020 | 31694957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3921/papers?page=31